Home/ESN cleer/Leopoldt de Bruin

LD

Leopoldt de Bruin

Managing Director, CEO

Therapeutic Areas

Cardiovascular Heart Failure

ESN cleer Pipeline

Drug	Indication	Phase
ESNtx005	Rare Cardiomyopathy	Preclinical

Leadership Team at ESN cleer

Prof. Andrew J. Stewart Coats

Executive Chair of the Board / Head of Medicine & Pharmaceutical President

Chief Commercial Officer

Gustav de Bruin

Chief Operating Officer, R&D and Regulatory

View full ESN cleer profile